Invivoscribe Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Invivoscribe's estimated annual revenue is currently $35.3M per year.(i)
  • Invivoscribe's estimated revenue per employee is $155,000

Employee Data

  • Invivoscribe has 228 Employees.(i)
  • Invivoscribe grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Invivoscribe is dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular biology, molecular diagnostics, and Personalized Molecular Medicine. Products manufactured in our GMP facility include a comprehensive selection of PCR-based reagents and controls for gene rearrangement, chromosome translocation, and gene mutation testing. Customers include pharmaceutical and biotechnology companies; cancer research, academic and hospital testing centers, and reference laboratories. Our CE-marked IVD products, which are available for sale and use outside North America, target biomarkers that have demonstrated clinical utility. Our tests are used to identify, stratify and monitor hematologic cancers. Our companion diagnostic products assist in the development of pharmaceutical agents and devices. Many of our gene rearrangement and gene mutation testing products are covered by exclusive-licensed patents.

keywords:Biotechnology,Healthcare

N/A

Total Funding

228

Number of Employees

$35.3M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$55.2M2289%N/A
#2
$15M22840%N/A
#3
$15M229-8%N/A
#4
$51.1M230-1%N/A
#5
$38.1M231-11%N/A